Biotechs seeking alternative sources for funding Rite Aid reports net revenue, $222 million loss for Q2 House votes to preserve choice for military pharmacy customers Ranbaxy's FDA woes could spell good news for Mylan General Mills sees boost in cereal sales for Q1 Kroger, shrugging off tough economy, posts respectable second-quarter gains Revlon shares rise after reverse stock split S&P rating of CVS unchanged in wake of Walgreens offer Economists critique candidates’ healthcare plans Hurdles for Walgreens could tilt Longs balance in CVS’ favor First Previous 310 311 312 313 314 Next Last
